Kalaris Therapeutics Inc Statistics Share Statistics Kalaris Therapeutics Inc has 18.7M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 18.7M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 74.18% Shares Floating n/a Failed to Deliver (FTD) Shares 2,282 FTD / Avg. Volume 0.83%
Short Selling Information The latest short interest is 186.96K, so 1% of the outstanding
shares have been sold short.
Short Interest 186.96K Short % of Shares Out 1% Short % of Float 3.95% Short Ratio (days to cover) 1.78
Valuation Ratios PE Ratio 0 Forward PE -0.81 PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kalaris Therapeutics Inc.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.85,
with a Debt / Equity ratio of 0.
Current Ratio 0.85 Quick Ratio 0.85 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -19.6
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.05M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Kalaris Therapeutics Inc's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 3.27 200-Day Moving Average n/a Relative Strength Index (RSI) 58.3 Average Volume (20 Days) 274,712
Income Statement
Revenue n/a Gross Profit n/a Operating Income -13.46M Net Income -14.7M EBITDA -14.01M EBIT -14.01M Earnings Per Share (EPS) 0
Full Income Statement Balance Sheet The company has 3.17M in cash and 0 in
debt, giving a net cash position of 3.17M.
Cash & Cash Equivalents 3.17M Total Debt n/a Net Cash n/a Retained Earnings -47.39M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.13M
and capital expenditures 0, giving a free cash flow of -14.13M.
Operating Cash Flow -14.13M Capital Expenditures n/a Free Cash Flow -14.13M FCF Per Share 0
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KLRS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for KLRS is $23,
which is 407.7% higher than the current price. The consensus rating is "Strong Buy".
Price Target $23 Price Target Difference 407.7% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 16, 2025. It was a
backward
split with a ratio of 1:23.
Last Split Date Jan 16, 2025 Split Type backward Split Ratio 1:23
Scores Altman Z-Score n/a Piotroski F-Score n/a
